Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.60 |
| ▸ | ORAI2 | Q96SN7 | 2/20 | 0.60 |
| ▸ | ORAI3 | Q9BRQ5 | 2/20 | 0.60 |
| ▸ | TRPV6 | Q9H1D0 | 2/20 | 0.60 |
| ▸ | CA4 | P22748 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16151497 | 0.88 | ORAI1 (0.48) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL16300534 | 0.85 | MGLL (0.50) | ORAI1ORAI2ORAI3TRPV6ALDH1A1 | |
| SCHEMBL309077 | 0.77 | CA4 (0.48) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL435243 | 0.75 | TRPV6 (1.00) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| Ammonia Solution, Strong SCHEMBL28822149 | 0.74 | CA4 (0.46) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL257958 | 0.74 | CA4 (0.46) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL14493121 | 0.72 | TRPV6 (0.48) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL4174839 | 0.72 | ORAI1 (0.46) | ORAI1ORAI2ORAI3TRPV6ALDH1A1 | |
| SCHEMBL4175868 | 0.72 | ENPP2 (0.46) | ORAI1ORAI2ORAI3TRPV6MEN1 | |
| SCHEMBL28993943 | 0.72 | CA4 (0.43) | ORAI1ORAI2ORAI3TRPV6CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116063604-B | Bimodal polyethylene resin for pipe material product, preparation method thereof and pipe material product | 中国石油化工股份有限公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-116063604-A | Bimodal polyethylene resin for pipe material product, preparation method thereof and pipe material product | 中国石油化工股份有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-112020520-B | Method for producing allyl monomer copolymer having polar group | 国立大学法人东京大学 | 2023-03-10 | — | — | CN | disclosed |
| US-20090082561-A1 | Methods For The Preparation Of Alkyl Diaryl Borinates And Complexed Diarylboronic Acids | THE PENNSYLVANIA STATE RESEARCH FOUNDATION | 2009-03-26 | — | — | US | disclosed |
| US-7405304-B2 | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids | THE PENN STATE RESEARCH FOUNDATION (US) | 2008-07-29 | — | — | US | disclosed |
| EP-0808849-B1 | Process for the production of ethylenic polymers | SHOWA DENKO KK (JP) | 2001-12-19 | — | — | EP | disclosed |
| US-6011127-A | CATALYST COMPRISING A CHROMIUM COMPOUND, AN ALUMOXANE AND AN ORGANOMETALLIC ALKOXIDE AND/OR ORGANOMETALLIC SILOXIDE AND A CARRIER SUPPORTING THEREON THESE COMPOUNDS. | SHOWA DENKO K.K. (JP) | 2000-01-04 | — | — | US | disclosed |
| EP-0574258-B1 | Process for producing alpha-olefin polymers | MITSUBISHI CHEM CORP (JP) | 1998-01-14 | — | — | EP | disclosed |
| EP-0808849-A1 | Process for the production of ethylenic polymers | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1997-11-26 | — | — | EP | disclosed |
| EP-0519496-B1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | TONEN CORP (JP) | 1996-05-22 | — | — | EP | disclosed |
| EP-0404503-B1 | Boron-containing, silicon nitride-based ceramic shaped body production process | TONEN CORP (JP) | 1996-03-06 | — | — | EP | disclosed |
| EP-0389084-B1 | Process for producing a polyborosilazane | TONEN CORP (JP) | 1995-09-20 | — | — | EP | disclosed |
| US-5292830-A | Silane, silazane, boron block crosslinked copolymers | TONEN CORPORATION (JP) | 1994-03-08 | — | — | US | disclosed |
| EP-0574258-A2 | Process for producing alpha-olefin polymers | MITSUBISHI CHEMICAL CORPORATION (JP) | 1993-12-15 | — | — | EP | disclosed |
| EP-0519496-A1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | Tonen Corporation (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5030744-A | Polyborosilazane and process for producing same | TONEN CORPORATION (JP) | 1991-07-09 | — | — | US | disclosed |
| EP-0404503-A1 | Boron-containing, silicon nitride-based ceramic shaped body production process | Tonen Corporation (JP) | 1990-12-27 | — | — | EP | disclosed |
| EP-0389084-A2 | Process for producing a polyborosilazane | Tonen Corporation (JP) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082561-A1 | Methods For The Preparation Of Alkyl Diaryl Borinates And Complexed Diarylboronic Acids | BCL6B, BLVRB, SSB | ORAI1 1065/4885ORAI2 874/4885ORAI3 747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.